Caricamento...
Enhancement of sialylation in rIgG in glyco-engineered Chinese hamster ovary cells
Since about 70% of commercial biopharmaceutical products have been produced in Chinese hamster ovary (CHO) cells, this cell line is undeniably a workhorse for biopharmaceuticals production. Meanwhile, sialic acid terminals were reported to affect anti-inflammatory activity, antibody-dependent cellul...
Salvato in:
| Pubblicato in: | Cytotechnology |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Netherlands
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7225233/ https://ncbi.nlm.nih.gov/pubmed/32125558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10616-020-00381-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|